Brought to you by 
Teva buys RPR's UK generic unit APS/Berk
29 Apr 2010
Executive Summary
Teva Pharmaceuticals, Israel's largest drug company, bought Rhone-Poulenc Rorer's UK generic drug division Applied Prescription Services and its subsidiaries (known collectively as APS/Berk for $53mm in cash (UK34mm).
Deal Industry
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Teva buys RPR's UK generic unit APS/Berk
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice